VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Corlieve Therapeutics

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 75 out of 100

  • Biotech & therapeutics
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Corlieve Therapeutics was a French biotech company, developing transformational therapies for neurological diseases. The lead program was a treatment for drug resistant temporal lobe epilepsy leveraging innovative gene therapy approaches. In June 2021, Corlieve was acquired by uniQure for up to € 250 million.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy